In RA in remission for >1 y, tapering TNFi to discontinuation did not meet noninferiority criteria compared with stable TNFi for disease flare at 12 mo.
rct · Level II
Where this comes from
- Record sourced from PubMed, PMID 38048575.
- Also identified by DOI 10.7326/J23-0095.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Lillegraven S, Paulshus Sundlisaeter N, Aga AB, et al. <b>Effect of tapered versus stable treatment with tumour necrosis factor inhibitors on disease flares in patients with rheumatoid arthritis in remission: a randomised, open label, non-inferiority trial.</b> Ann Rheum Dis. 2023;82:1394-1403. 37607809.
Medical subject headings
- Antirheumatic Agents
- Arthritis, Rheumatoid